Meso
Emerging
Active
Interesse do mercado no receptor de orexina
Pontuação
0,4
Velocidade
▲ 0,0
Artigos
1
Fontes
1
Resumo
Um artigo pertence a esta narrativa se for sobre o crescente interesse ou investimento no mercado de agonistas do receptor de orexina.
Hipóteses
Pending
Prazo: 1 de Junho de 2026
ALKS stock volatility (30-day implied volatility) will increase by at least 25% within 60 days as market participants price in orexin receptor commercial opportunity potential
Pending
Prazo: 31 de Julho de 2026
Orexin receptor market expansion will result in ALKS achieving a market capitalization increase of at least 20% within 120 days, driven by investor sentiment and pipeline expansion expectations
Pending
Prazo: 1 de Julho de 2026
Increasing orexin receptor agonist market interest will drive ALKS stock price to outperform the broader biotech sector (XBI) by at least 15% within 90 days
Fontes
Cronologia
Última atualização
Abr 02, 2026